SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending amidst sharp debate over its deep correlation to a volatile crypto market and a significant report suggesting the U.S. government is considering it to manage proposed "Trump accounts" for children, fueling both speculative buying and short interest ahead of upcoming earnings.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Natural gas ETFs are experiencing extreme volatility, with futures plummeting due to revised forecasts signaling a warmer February, while a segment of the community remains bullish on a potential extended cold snap, making for a 'widowmaker' market environment.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending after reporting strong earnings and an optimistic outlook, driven by surging demand for memory products vital to the AI sector. The community is intensely debating whether the current parabolic rally reflects unprecedented growth or an overextended valuation primed for a significant pullback.

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.

Atossa Therapeutics Inc

Atossa Therapeutics is trending amidst an impending 1-for-15 reverse stock split and the recent FDA Orphan Drug Designation for (Z)-Endoxifen in Duchenne Muscular Dystrophy. The community is fiercely debating the split as a "scam" by CEO Steven Quay to dilute shares and fund salaries, leading to widespread investor frustration over perceived mismanagement and significant losses despite potential drug efficacy.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical (PBM) is experiencing significant market attention and extreme volatility following its reverse stock split, which has created a low float and ignited widespread speculation for a potential short squeeze. Traders are actively discussing recent positive developments like clinical trial progress for its psilocybin product, a share buyback authorization, and a major institutional investment, contrasting with concerns over the company's history of reverse splits and trading halts.

Julong Holding Ltd. is a holding company, which operates as an investment holding company. It provides intelligent integrated solutions to public utilities, enterprises, commercial, and multifamily properties. The company was founded by Jiaqi Hu on August 07, 2023 and is headquartered in Beijing, China.

Julong Holding Ltd. - Ordinary Shares - Class A

JLHL is trending due to extreme volatility and frequent trading halts, with the community actively debating whether this micro-float 'Hong Kong play' represents a setup for a massive short squeeze or a rapid pump-and-dump, often noted for its lack of fundamental news.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is trending after exceeding Q1 earnings expectations, fueled by record Experiences revenue and accelerating streaming profitability, coupled with a significant share buyback and dividend hike. However, community discussion reflects a "sell the news" reaction and ongoing debate surrounding its content strategy and future leadership transition, despite strong financial results.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is surging with massive gains as natural gas futures plunge significantly, driven by forecasts of warmer weather ahead and potential de-escalation of geopolitical tensions. The community is actively trading its extreme volatility, with many either locking in substantial profits or accumulating for further potential upside as winter demand eases.

VenHub Global, Inc. engages in the management of fully autonomous and robotic-operated convenience stores. It is involved in utilizing technologies such as artificial intelligence (AI) and smart inventory management systems for shopping experience of customers. The company was founded by Shahan Ohanessian and Shoushana Ohanessian on January 31, 2023 and is headquartered in Pasadena, CA.

Venhub Global Inc.

Venhub Global (VHUB) is experiencing a significant surge following its Nasdaq direct listing and news of an Amazon Web Services executive joining to lead global expansion for its autonomous store technology. The community is actively discussing a potential short squeeze, citing its low float and high after-hours volume as key drivers.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is rallying on strong economic data, including an expanding ISM Manufacturing PMI, and a new US-India trade deal reducing tariffs and redirecting oil purchases. The market's upward momentum is igniting heated debate, with many celebrating new highs while others decry perceived manipulation designed to squeeze bears and options traders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Citius Pharmaceuticals (CTXR) Surges 22% After Hours Here's Why

Citius Pharmaceuticals shares jumped 22.12% after hours following the commercial launch of its LYMPHIR therapy and a fiscal 2025 business update.read more...

Citius Pharmaceuticals Inc. Full Year Loss Decreases

(RTTNews) - Citius Pharmaceuticals Inc. (CTXR.OB) released Loss for full year of -$37.43 million...

Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update

Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update PR Newswire...

Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update

Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business...

Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules

Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules Citius Oncology Announces Closing of $18 Million...

Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules

Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules Citius Oncology Announces $18 Million Concurrent Registered...

Citius Oncology Expands LYMPHIR Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim

Citius Oncology Expands LYMPHIR Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim Citius Oncology Expands LYMPHIR Distribution to Turkey and Middle East...

Citius Oncology Announces U.S. Commercial Launch of LYMPHIR, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)

Citius Oncology Announces U.S. Commercial Launch of LYMPHIR, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL) Citius Oncology Announces U.S. Commercial Launch of LYMPHIR, a Novel...

Citius Oncology to Advance Commercial Launch of LYMPHIR with Verix AI Integration

Citius Oncology to Advance Commercial Launch of LYMPHIR with Verix AI Integration Citius Oncology to Advance Commercial Launch of LYMPHIR with Verix AI Integration PR Newswire CRANFORD, N.J., Nov...

Citius Pharmaceuticals Announces the Closing of Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules

Citius Pharmaceuticals Announces the Closing of Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules Citius Pharmaceuticals Announces the Closing of Registered Direct...

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone, Leonard Mazur, Myron Holubiak on January 23, 2007 and is headquartered in Cranford, NJ.

Citius Pharmaceuticals Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $AMD earnings on Tuesday?

CTXR
Citius Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CTXR News

CTXRCitius Pharmaceuticals Inc